View Author
cancer breast mutation breast cancer family colorectal breast cancer cases chek 2 colorectal cancer susceptibility tumor allele expression brca 1 protein study breast cancer risk patient control table variant colorectal cancer cases wild-type analysis genet population frequency hnpcc cohort mutyh carrier brca 2 mutations chapter dutch germline breast cancer res breast cancers cell lines syndrome netherland sample chek 2 gene klijn phenotype pathway transcript breast cancer families chek 2*1100delc kinase criteria result meijers-heijboer schutte van den ouweland wasielewski identi polygenic figure breast cancer patients polyposi +++ individual chek 2 mutations unselected model mutyh mutations breast cancer risks 1/brca colorectal cancer patients status germline mutations repair colorectal cancer risk colorectal cancer families nonpolyposis colorectal cancer number signature klijn jg hnpcc-related non-polyposis colorectal cancer
10 Most Recent Publications
|
Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes
(Article)
Nagel, J.H.A. Peeters, J. Klijn, J.G.M. Spek, P.J. van der Foekens, J.A. Martens, J.W.M. Schutte, M. Meijers-Heijboer, H. Smid, M. Sieuwerts, A.M. Wasielewski, M. Weerd, V. de Trapman-Jansen, A.M.A.C. Ouweland, A.M.W. van den Brüggenwirth, H.T. IJcken, W.F.J. van |
2011-05-26
|
|
Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines
(Article)
Hollestelle, A. Nagel, J.H.A. Riaz, M. Koopman, D.G. Hagen, T.L.M. ten Leeuw, B. de Zwarthoff, E.C. Teunisse, A. Spek, P.J. van der Klijn, J.G.M. Dinjens, W.N.M. Ethier, S.P. Smid, M. Clevers, H.C. Jochemsen, A.G. Bakker, M.A. den Foekens, J.A. Martens, J.W.M. Schutte, A.E.M. Lam, S. Elstrodt, F. Wasielewski, M. Ng, S.S. French, P.J. Peeters, J. Rozendaal, M.J. |
2010-05-01
|
|
CHEK2 1100delC and polygenic susceptibility to breast cancer and colorectal cancer
(Doctoral Thesis)
Wasielewski, M. |
2009-04-29
|
|
Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines
(Article)
Wasielewski, M. Hanifi-Moghaddam, P. Hollestelle, A. Merajver, S.D. Ouweland, A.M.W. van den Klijn, J.G.M. Ethier, S.P. Schutte, A.E.M. |
2009-01-01
|
|
Exon expression arrays as a tool to identify new cancer genes
(Article)
Schutte, M. Elstrodt, F. Sillevis Smitt, P.A.E. French, P.J. Bralten, L.B.C. Nagel, J.H.A. Duijm, E. Hollestelle, A. Vuerhard, M.J. Wasielewski, M. Peeters, J.K. Spek, P.J. van der |
2008-08-20
|
|
CHEK2 1100delC is a susceptibility allele for HNPCC-related colorectal cancer
(Article)
Wasielewski, M. Vasen, H. Wijnen, J. Hooning, M. Dooijes, D. Tops, C. Klijn, J.G.M. Meijers-Heijboer, E.J. Schutte, M. |
2008-08-01
|
|
CHEK2 1100delC and male breast cancer in the Netherlands
(Article)
Wasielewski, M. Bakker, M.A. den Ouweland, A.M.W. van den Meijer van Gelder, M.E. Portengen, H. Klijn, J.G.M. Meijers-Heijboer, E.J. Foekens, J.A. Schutte, M. |
2008-01-01
|
|
MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling
(Article)
Wasielewski, M. Nagel, J.H.A. Brekelmans, C.T. Klijn, J.G.M. Ouweland, A.M.W. van den Meijers-Heijboer, E.J. Schutte, A.E.M. |
2007-08-01
|
|
The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype
(Article)
Meijers-Heijboer, E.J. Moslein, G. Bos, R.R. van den Snoo, A. de Schutte, A.E.M. Franken, P.F. Fat, G.T. Jagmohan, S. Chapman, P. Brekelmans, C.T. Wijnen, J. Vasen, H. Lynch, H. Ouweland, A.M.W. van den Klijn, J.G.M. Hollestelle, A. Wasielewski, M. Fodde, R. Wagner, A. Elstrodt, F. Verkuijlen, P. Tops, C. Burn, J. |
2003-01-01
|
|
Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility
(Article)
Schutte, A.E.M. Meijers-Heijboer, E.J. Nathanson, K.L. Futreal, P.A. Stratton, M.R. Seal, S. Barfoot, R. Ouweland, A.M.W. van den Klijn, J.G.M. Easton, D.F. Wasielewski, M. Evans, D.G. Eccles, D. Weber, B.L. Rahman, N. Meijers, C. Lohman, F. |
2003-01-01
|
